Literature DB >> 17489

A practical chromogenic procedure for the diagnosis of Krabbe's disease.

A E Gal, R O Brady, P G Pentchev, F S Furbish, K Suzuki, H Tanaka, E L Schneider.   

Abstract

Krabbe's disease is caused by a deficiency of galactocerebrosidase in organs and tissues. Determinations of galactocerebrosidase activity had required the use of galactocerebroside labeled with radiocarbon or radiohydrogen. These materials are expensive and their use is restricted to laboratories with radioactive counting facilities. An analogue of galactocerebroside, 2-hexadecanoylamino-4-nitrophenyl-beta-D-galactopyranoside, was synthesized. The hydrolysis of this analogue by extracts of tissues and cells from patients with Krabbe's disease is greatly reduced from normal levels. Cultured skin fibroblasts preparations derived from heterozygous carriers of Krabbe's disease have an intermediate level of hydrolytic activity. Thus, the analogue is a reliable chromogenic reagent for the diagnosis of patients with Krabbe's disease and for the detection of heterozygous carriers of the Krabbe trait.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 17489     DOI: 10.1016/0009-8981(77)90401-6

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  4 in total

Review 1.  Basic findings and current developments in sphingolipidoses.

Authors:  H Pilz; R Heipertz; D Seidel
Journal:  Hum Genet       Date:  1979-03-12       Impact factor: 4.132

2.  Diagnosis and prevention of lysosomal storage diseases in Russia.

Authors:  K D Krasnopolskaya; T V Mirenburg; E L Aronovich; T V Lebedeva; O N Odinokova; N A Demina; V M Kozlova; M I Kuznetsov
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

3.  The use of natural and artifical substrates in the prenatal diagnosis of Krabbe's disease.

Authors:  G T Besley
Journal:  J Inherit Metab Dis       Date:  1978       Impact factor: 4.982

4.  Molecular characterization of mutations that cause globoid cell leukodystrophy and pharmacological rescue using small molecule chemical chaperones.

Authors:  Wing C Lee; Dongcheul Kang; Ena Causevic; Aimee R Herdt; Elizabeth A Eckman; Christopher B Eckman
Journal:  J Neurosci       Date:  2010-04-21       Impact factor: 6.167

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.